CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia... Show more
A.I.dvisor indicates that over the last year, CCEP has been loosely correlated with MNST. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CCEP jumps, then MNST could also see price increases.
| Ticker / NAME | Correlation To CCEP | 1D Price Change % | ||
|---|---|---|---|---|
| CCEP | 100% | +0.29% | ||
| MNST - CCEP | 47% Loosely correlated | -1.03% | ||
| PEP - CCEP | 47% Loosely correlated | +0.49% | ||
| COKE - CCEP | 39% Loosely correlated | -1.55% | ||
| KDP - CCEP | 39% Loosely correlated | -0.27% | ||
| FIZZ - CCEP | 29% Poorly correlated | +2.61% | ||
More | ||||
a bottling company with interests in marketing, production and distribution of Coca-Cola products
Industry BeveragesNonAlcoholic
The RSI Oscillator for CCEP moved out of oversold territory on September 21, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In 11 of the 17 cases the stock moved higher. This puts the odds of a move higher at 65%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on CCEP as a result. In 48 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 48%.
The Moving Average Convergence Divergence (MACD) for CCEP just turned positive on September 29, 2026. Looking at past instances where CCEP's MACD turned positive, the stock continued to rise in 24 of 48 cases over the following month. The odds of a continued upward trend are 50%.
CCEP moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEP advanced for three days, in 190 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for CCEP crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCEP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 36%.
CCEP broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CCEP entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.803) is normal, around the industry mean (6.793). P/E Ratio (20.364) is within average values for comparable stocks, (43.051). Projected Growth (PEG Ratio) (2.715) is also within normal values, averaging (3.732). Dividend Yield (0.023) settles around the average of (0.014) among similar stocks. P/S Ratio (1.873) is also within normal values, averaging (2.785).
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. CCEP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.